Skip to main content
. 2016 Feb 12;28(6):861–870. doi: 10.1111/nmo.12784

Figure 5.

Figure 5

Motility of the ascending colon for functional constipation (FC) and irritable bowel syndrome with constipation (IBS‐C) patients during the study day. Motility for IBS‐C rapidly rose from baseline and peaked at 120 min from the start of Moviprep® ingestion when the motility for IBS‐C was significantly elevated at 0.107 (0.070) compared to FC 0.055 (0.044), p < 0.01.